|
|
Volumn 21, Issue 1, 2002, Pages 213-220
|
|
CD95/CD95 ligand-independent potentiation of treosulfan cytotoxicity by BSO in malignant glioma cells in vitro and in vivo.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
BUSULFAN;
BUTHIONINE SULFOXIMINE;
DRUG DERIVATIVE;
FAS ANTIGEN;
FAS LIGAND;
FASLG PROTEIN, HUMAN;
GLUTATHIONE;
LIGAND;
MEMBRANE PROTEIN;
TNFSF6 PROTEIN, RAT;
TREOSULFAN;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL;
APOPTOSIS;
ARTICLE;
BLOOD CELL COUNT;
BRAIN TUMOR;
CANCER TRANSPLANTATION;
CELL CULTURE;
CELL DIVISION;
DRUG EFFECT;
DRUG POTENTIATION;
GENE TRANSFER;
GENETICS;
GLIOMA;
HUMAN;
IN VITRO STUDY;
METABOLISM;
PATHOLOGY;
RAT;
SPRAGUE DAWLEY RAT;
SURVIVAL RATE;
ANIMALS;
ANTIGENS, CD95;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
APOPTOSIS;
BLOOD CELL COUNT;
BRAIN NEOPLASMS;
BUSULFAN;
BUTHIONINE SULFOXIMINE;
CELL DIVISION;
DRUG SYNERGISM;
FAS LIGAND PROTEIN;
GENE TRANSFER TECHNIQUES;
GLIOMA;
GLUTATHIONE;
HUMANS;
LIGANDS;
MEMBRANE GLYCOPROTEINS;
NEOPLASM TRANSPLANTATION;
RATS;
RATS, SPRAGUE-DAWLEY;
SURVIVAL RATE;
TUMOR CELLS, CULTURED;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
|
EID: 0036654587
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.21.1.213 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
